Jellatech, Inc.
Bio-identical complex proteins produced via cellular agriculture and synthetic biology
- Sector
- Biotech
- Headquarters
- RALEIGH, NC
- Founded
- 2020
- Latest Form D
- $100K, Sep 2023
- Total capital
- $6.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $6.5M
- 7 Form D · last Sep 2023
- 38 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$100K
- Private capital raisedForm D · SEC · 6th filing$3.5M
- Private capital raisedForm D · SEC · 5th filing$926K
- Private capital raisedForm D · SEC · 4th filing$75K
- Private capital raisedForm D · SEC · 3rd filing$165K
- Private capital raisedForm D · SEC · 2nd filing$975K
- Private capital raisedForm D · SEC · 1st filing$725K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Peter AndersenDirectorNamed in SEC Form D filings
- Ryan BethencourtDirectorNamed in SEC Form D filings
- Stephanie MichelsenExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingMethod For Producing A Material Using Collagen From Cultured Animal CellsUSPTOApplication 17686414
- PendingProduce And Isolate And/or Extract Collagen And/or Gelatin From Animal Cell Lines And/or Tissue ExplantsUSPTOApplication 17497455
- PendingMethod For Producing A Material Using Collagen From Cultured Animal CellsUSPTOApplication PCTUS2022018817
Show all 6 patent records
- Method For Producing A Material Using Collagen From Cultured Animal CellsSep 8, 2022 · Application 17686414Pending
- Produce And Isolate And/or Extract Collagen And/or Gelatin From Animal Cell Lines And/or Tissue ExplantsApr 14, 2022 · Application 17497455Pending
- Method For Producing A Material Using Collagen From Cultured Animal CellsApplication PCTUS2022018817Pending
- Produce And Isolate And/or Extract Collagen And/or Gelatin From Animal Cell Lines And/or Tissue ExplantsApplication PCTUS2021054208Pending
- Method For Producing A Material Using Collagen From Cultured Animal CellsApplication 63156636Pending
- Produce And Isolate And/or Extract Collagen And/or Gelatin From Animal Cell Lines And/or Tissue ExplantsApplication 63089285Pending
Related companies, and why
- BTB Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Saccharo, Inc.Similar federal contract value in Biotech · null in contracts
- Cytosolix, Inc.Similar federal contract value in Biotech · null in contracts
- Moleculin, LLCSimilar federal contract value in Biotech · null in contracts
- Biolexis Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Hilltop Biosciences Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .